Davor Puljević

ORCID: 0000-0003-3603-2242
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Syncope and Autonomic Disorders
  • ECG Monitoring and Analysis
  • Cardiovascular Function and Risk Factors
  • Transplantation: Methods and Outcomes
  • Regional Development and Management Studies
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Cerebrovascular and Carotid Artery Diseases
  • Neurological disorders and treatments
  • Hemodynamic Monitoring and Therapy
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Valve Diseases and Treatments
  • Hepatitis B Virus Studies
  • Pharmacogenetics and Drug Metabolism
  • Cardiac Arrest and Resuscitation
  • Hepatitis Viruses Studies and Epidemiology
  • Cardiac tumors and thrombi
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Ion channel regulation and function

University Hospital Centre Zagreb
2015-2025

University of Zagreb
2015-2025

University of Rochester Medical Center
2019

University of Dubrovnik
2015

Michele Brignole Andrés Moyá Frederik J. de Lange Jean‐Claude Deharo Perry Elliott and 95 more Alessandra Fanciulli Artur Fedorowski Raffaello Furlan Rose Anne Kenny Alfonso Martı́n Vincent Probst Matthew J. Reed Ciara Rice Richard Sutton Andrea Ungar J. Gert van Dijk Adam Torbicki Javier Moreno Victor Aboyans Stefan Agewall Riccardo Asteggiano Jean‐Jacques Blanc Natan Bornstein Serge Bovéda Héctor Bueno Haran Burri António Coca Jean‐Philippe Collet Giorgio Costantino Ernesto Díaz‐Infante Victoria Delgado Faas Dolmans Oliver Gaemperli Jacek Gajek Gerhard Hindricks Josef Kautzner Juhani Knuuti Piotr Kułakowski Ekaterini Lambrinou Christophe Leclercq Philippe Mabo Carlos A. Morillo Massimo Piepoli Marco Roffi Win K. Shen Iain A. Simpson Martin Stockburger Peter Vanbrabant Stephan Windecker José Luis Zamorano Stephan Windecker Victor Aboyans Stefan Agewall Emanuele Barbato Héctor Bueno António Coca Jean‐Philippe Collet Ioan Mircea Coman Verónica Dean Victoria Delgado Donna Fitzsimons Oliver Gaemperli Gerhard Hindricks Bernard Iung Peter Jüni Hugo A. Katus Juhani Knuuti Patrizio Lancellotti Christophe Leclercq Theresa McDonagh Massimo Piepoli Piotr Ponikowski Dimitrios Richter Marco Roffi Е. V. Shlyakhto Miguel Sousa‐Uva Iain A. Simpson José Luis Zamorano Franz Xaver Roithinger Alexandr Chasnoits Yves Vandekerckhove Vasil B Traykov Davor Puljević Elias Papasavvas Josef Kautzner Henning Mølgaard Mostafa Nawar Hannu Parikka Marija Vavlukis Olivier Piot Kakhaber Etsadashvili Thomas Klingenheben Spyridon Deftereos László Sághy Kristján Guðmundsson Roy Beinart Antonio Raviele Ayan Abdrakhmanov Erkin М Мirrakhimov Oskars Kalējs

10.1093/eurheartj/ehy037 article EN European Heart Journal 2018-03-19

Implantable cardioverter defibrillators (ICDs) have significantly reduced the incidence of sudden cardiac death in patients with heart failure, particularly those ischemic disease. However, impact on overall mortality remains controversial, especially non-ischemic failure patients. The Danish Study to Assess Efficacy ICDs Patients Non-Ischemic Systolic Heart Failure (DANISH) trial and subsequent studies questioned efficacy this population, among older present study aimed evaluate survival...

10.31083/rcm26349 article EN cc-by Reviews in Cardiovascular Medicine 2025-04-16

Abstract Introduction Evidence indicates that pulmonary vein isolation (PVI) is more effective than antiarrhythmic medications in maintaining sinus rhythm atrial fibrillation (AF) and enhancing quality of life¹. As such, PVI recommended as a first-line control treatment for paroxysmal AF patients². Recent research highlights early may be associated with better clinical outcomes³. However, significant barriers patient education healthcare logistics hinder the widespread adoption this approach...

10.1093/europace/euaf085.405 article EN cc-by-nc EP Europace 2025-05-01

Abstract Background Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death (SCD) in heart failure (HF) patients, especially those with ischemic cardiomyopathy (ICM). However, the overall impact on mortality non-ischemic (NICM) is still debated. The DANISH trial raised questions about ICD efficacy NICM particularly older individuals, sparking concerns regarding patient selection and risk-benefit balance. This study evaluates survival outcomes, device activation, predictors...

10.1093/europace/euaf085.754 article EN cc-by-nc EP Europace 2025-05-01

The aim of the study was to determine relation between QT dispersion and ventricular arrhythmia after myocardial infarction, as well effects postinfarction scar size, cardiac function, severity coronary artery disease on dispersion. Three hundred three patients, 3 months a group 21 healthy subjects were evaluated. difference maximal minimal interval in 12‐ECG leads. Postinfarction size determined by Selvester's QRS scoring system. Cardiac function evaluated echocardiography exercise stress...

10.1111/j.1540-8159.1998.tb00237.x article EN Pacing and Clinical Electrophysiology 1998-08-01

Intra-cardiac echocardiography (ICE) has become an important tool for catheter ablation. Adoption of ICE imaging is still limited because its prohibitively high cost. Our aim was to study the safety and feasibility catheters reprocessing environmental financial impact.This a single center retrospective analysis all consecutive electrophysiology procedures in which were used from 2015 2022. In total, 1128 patients studied (70.6% male, mean age 57.9 ± 13.2 years). The majority related atrial...

10.1186/s12947-023-00318-4 article EN cc-by Cardiovascular Ultrasound 2023-10-26

The aim of the study was to determine value and correlation between QT dispersion, daily variations in interval late potentials as risk markers for ventricular tachycardia.QT dispersion defined difference longest shortest 12 electrocardiographic leads, QTc variability maximal minimal during 24-h Holter monitoring adaptation regression line heart rate uncorrected interval. One hundred forty-five patients, 3 months after myocardial infarction were included study. significantly increased with...

10.1093/oxfordjournals.eurheartj.a015448 article EN European Heart Journal 1997-08-02

Abstract Aims Microvolt T‐wave alternans (MTWA) testing is a beat‐to‐beat fluctuation in the amplitude of T wave. We investigated whether: (a) MTWA can be new non‐invasive tool for detection reversible ischemia patients with suspected CAD without structural heart disease, (b) detect earlier and greater test accuracy compared exercise ECG ST‐segment testing, (c) threshold value rate at which estimated different to standard values. Methods A total 101 stable coronary but were included....

10.1111/anec.12610 article EN Annals of Noninvasive Electrocardiology 2018-11-01

To examine the learning curves of atrial fibrillation (AF) ablation comparing cryoballoon (CB) and radiofrequency (RF) catheters.We performed a retrospective data analysis from initiation AF program in our center. For CB ablation, second generation 28 mm balloon was utilized for RF ablation.A total 100 consecutive patients (50 each group) have been enrolled study (male 74%, mean age 58.9 ± 10 years, paroxysmal 85%). The procedure time shorter (116.6 39.8 min) than group (191.8 101.1 (p <...

10.1016/j.ipej.2020.09.003 article EN cc-by-nc-nd Indian Pacing and Electrophysiology Journal 2020-09-30

Background: This study was conducted to evaluate compliance with guideline-directed optimal medical therapy (OMT) and its association early implantable cardioverter-defibrillator (ICD) activation in patients heart failure reduced ejection fraction (HFrEF). Methods: Retrospective data from 307 who underwent ICD implantation for primary prevention 2011 2017 were collected analyzed. Results: Among the participants, only 23.8% received maximum tolerated dose of OMT prior implantation, 59.0%...

10.31083/j.rcm2503075 article EN cc-by Reviews in Cardiovascular Medicine 2024-02-27

Abstract Background Pulmonary vein isolation (PVI) is the standard of care for patients with atrial fibrillation (AF), but medium-term success rates are far from ideal. Therefore, new methods being developed, emphasis on ectopic foci outside pulmonary veins. Superior vena cava (SVC) one most important non-pulmonary origins AF and some studies suggested that empiric SVC could improve outcomes in ablation paroxysmal (PAF). Although complications have been reported ablation, found complication...

10.1093/europace/euae102.209 article EN cc-by-nc EP Europace 2024-05-01

Abstract Background Atrial fibrillation is the most common arrhythmia in general population and cryoballoon ablation gradually becoming a first-line treatment. However, data regarding long-term outcomes after this procedure are still lacking. Aim The goal was to show results of follow-up following pulmonary vein isolation patients with atrial (AF). Methods A total 126 were included study which 77.0% had paroxysmal (PAF). Successful treatment outcome defined as AF recurrence-free survival...

10.1093/europace/euae102.221 article EN cc-by-nc EP Europace 2024-05-01

Abstract Introduction There are a variety of approaches for pre-procedural imaging to facilitate atrial fibrillation (AF) ablation. Intra-procedural three-dimensional rotational angiography (3DRA) is the least employed method and it can be advantageous regarding efficiency procedural logistics (1). an open question whether LA could improve safety outcomes cryoballoon (CB) Purpose The aim this study evaluate possible benefits 3DRA success, long-term CB Methods We designed single-centre...

10.1093/europace/euae102.122 article EN cc-by-nc EP Europace 2024-05-01
Coming Soon ...